Tag Archives: Perception

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »

Survey Reveals Disconnect Between Perception and Reality of Medical Device Security

The U.S. Department and Health and Human Services (HHS) this week officially opened the Health Sector Cybersecurity Coordination Center (HC3), designed to strengthen coordination and cybersecurity information sharing within the healthcare sector and promote cybersecurity resilience. According to HHS officials, HC3 is an operational cybersecurity center designed to support and improve the cyber defense of… Read More »